Who invested in Civitas Therapeutics

5 rounds we have observed, with the 13 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$122Mraised across 5 rounds since 2011, from 5 sources

$20MSeries A$8.0MSeries A$1.0MGrant$38MSeries B$55MSeries C

Latest round: Series C, $55MAug 2014
Step-upi: 1.4×
Investors: 13

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2011201220132014

$20MSeries A$8.0MSeries A$1.0MGrant$38MSeries B$55MSeries C

First round: Series A, $20M
Biggest round: $55M
Usual gap between rounds: 11 months

The rounds

Aug 2014
Series C$55M6 new6 returning
From a historical funding recordSEC filing: $55M sold, first sale Aug 2014
Sept 2013
Series B$38M5 new2 returning
- Canaan
- RA Capital Management
- Longitude Capital
- Bay City Capital
- Fountain Healthcare Partners
- Alkermes
- City Capital
Reported by finsmes.comSEC filing: $38M sold, first sale Sept 2013
Jun 2013
Grant$1.0M
No investor was named in the report.
Reported by xconomy.comSEC filing: $38M sold, first sale Sept 2013
May 2011
Series A$8.0M
No investor was named in the report.
Reported by masshightech.comSEC filing: $14M sold, first sale Dec 2010
Jan 2011
Series A$20M2 new
- Canaan
- Longitude Capital
Reported by finsmes.comSEC filing: $10M sold, first sale Dec 2010

Founders and team

From the SEC filings it signed: 6 on the team.

Andrea FranzExecutive Officeri
Bryan StuartExecutive Officeri
Mark IwickiExecutive Officer, Directori
Martin FreedExecutive Officeri
Mary TaylorExecutive Officeri
Richard BatyckyExecutive Officeri

On the board, as filediAidan KingBlair JacksonDavid HirschGlenn BatchelderRajeev S. ShahRob HopfnerRobert S. RocheTim S. ShannonTimothy S. Nelson

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2011Series A2011Grant2013Series B2013Series C2014

Canaan

Longitude Capital

RA Capital Management

Bay City Capital

Fountain Healthcare Partners

Alkermes

OrbiMed

Wellington Management

Sofinnova InvestmentsAdage Capital Management

The exit

ExitBuyerPriceWhen

AcquiredAcorda Therapeutics$525MSept 2014

From historical deal records. Wrong? Tell us.

Everyone who backed them

CanaanVC firm3rounds

Longitude CapitalVC firm3rounds

RA Capital ManagementPrivate equity2rounds

Bay City CapitalVC firm2rounds

Fountain Healthcare PartnersVC firm2rounds

AlkermesCorporate VC2rounds

OrbiMedPrivate equity1round

Wellington ManagementVC firm1round

Sofinnova InvestmentsVC firm1round

Adage Capital ManagementAsset manager1round

Rock Springs CapitalHedge fund1round

Partner Fund Management (PFM)Growth equity1round

City Capitalno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Civitas Therapeutics

Who invested in Civitas Therapeutics?

Civitas Therapeutics's investors include Canaan, Longitude Capital, RA Capital Management, Bay City Capital and Fountain Healthcare Partners, and 8 more on record.